Publications Prior to 2018
- Thangamani S, M. Maland, H. Mohammad, P. Pascuzzi, L. Avramova, C. Koehler, T. R. Hazbun and M. N. Seleem. Repurposing approach identifies auranofin with broad-spectrum antifungal activity that targets Mia40-Erv1 pathway, Frontiers in Cellular and Infection Microbiology (2017)
- Thangamani S, H. E. Eldesouky, H. Mohammad, P. Pascuzzi, L. Avramova, T. R. Hazbun and M. N. Seleem. Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells. BBA- General Subjects (2017)
- Thangamani S, Mohammad H, Abushahba MF, Hamed MI, Sobreira TJ, Hedrick VE, Paul LN, Seleem MN. Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Scientific Reports (2016)
- Thangamani S, Mohammad H, Abushahba MF, Hamed MI, Sobreira TJ, Hedrick VE, Paul LN, Seleem MN. Repurposing auranofin for the treatment of cutaneous staphylococcal infections. International Journal of Antimicrobial Agents and Chemotherapy (2016)
- Abushahba MF, Mohammad H, Thangamani S, Hussein AA, Seleem MN. Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens. Scientific Reports (2016)
- Thangamani S, Mohammad H, Abushahba MF, Hamed MI, Sobreira TJ, Hedrick VE, Paul LN, Seleem MN. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Scientific Reports (2015)
- Thangamani S, Nepal M, Chmielewski J, Seleem MN. Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection. Drug Des Devel Ther (2015)
- Thangamani S, Younis W, Seleem MN. Repurposing celecoxib as a topical antimicrobial agent. Frontiers in Microbiology (2015)
- Thangamani S, Younis W, Seleem MN. Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens. PLoS One (2015)
- Thangamani S, Younis W, Seleem MN. Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections. Scientific Reports (2015)
- Younis W, Thangamani S, Seleem MN. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections Current Pharmaceutical Design (2015)
- Nepal M, Thangamani S, Seleem MN, Chmielewski J. Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helix. Organic and Biomolecular Chemistry (2015)
- Mohammad H, Thangamani S, Seleem MN. Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infections. Current Pharmaceutical Design (2015)
- Thangamani S, Mohammad H, Younis W, Seleem MN. Drug repurposing for the treatment of staphylococcal infections. Current Pharmaceutical Design (2015)
- Thangamani S*, Kim M*, Son Y, Huang X, Kim H, Lee JH, Cho J, Ulrich B, Broxmeyer HE, Kim CH. Cutting edge: progesterone directly up regulates vitamin d receptor gene expression for efficient regulation of T cells by calcitriol. Journal of Immunology (2015). (* Co-first authors)
- Wang C*, Thangamani S*, Kim M, Gu BH, Lee JH, Taparowsky EJ, Kim CH. BATF is required for normal expression of gut-homing receptors by T helper cells in response to retinoic acid. Journal of Experimental Medicine (2013) (* Co-first authors)
- Chang J, Thangamani S, Kim MH, Ulrich B, Morris SM Jr, Kim CH. Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation. European Journal of Immunology (2013).